Current developments in the immunology of psoriasis

Franziska Grän, Andreas Kerstan, Edgar Serfling, Matthias Goebeler, Khalid Muhammad

Research output: Contribution to journalReview articlepeer-review

128 Citations (Scopus)


Psoriasis is a frequent inflammatory skin disease. Fundamental research on the pathogenesis of psoriasis has substantially increased our understanding of skin immunology, which has helped to introduce innovative and highly effective therapies. Psoriasis is a largely T lymphocyte-mediated disease in which activation of innate immune cells and pathogenic T cells result in skin inflammation and hyperproliferation of keratinocytes. B cells have thus far largely been neglected regarding their role for the pathogenesis of psoriasis. However, recent data shed light on their role in inflammatory skin diseases. Interestingly, interleukin (IL)-10-producing regulatory B cells have been assumed to ameliorate psoriasis. In this review, we will discuss the development of disease, pathogenicity, and current developments in therapeutic options. We describe different roles of T cells, B cells, and cytokines for the immunopathology and disease course of psoriasis.

Original languageEnglish
Pages (from-to)97-110
Number of pages14
JournalYale Journal of Biology and Medicine
Issue number1
Publication statusPublished - Mar 2020


  • Biologics
  • Cytokines
  • Lymphocytes
  • Psoriasis
  • Regulatory B cells

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology


Dive into the research topics of 'Current developments in the immunology of psoriasis'. Together they form a unique fingerprint.

Cite this